Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Candidiasis Vaccines
Investigators at Palacky University, Department of Immunology target candidiasis vaccines
September 17th, 2008
A new study, 'Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis,' is now available. "The Candida albicans heat shock protein 90 kDa (hsp90-CA) is an important target for protective antibodies in disseminated candidiasis of experimental mice and humans. Hsp90-CA is present in the cell wall of Candida pseudohyphae or hyphae--typical pathogenic morphotypes in both mucosal and systemic Candida infections," scientists in Olomouc, Czech Republic report. "However, the potential protective effects of hsp90-CA-specific antibodies in...
Source: Vaccine Weekly (2008-09-17)
|
